FDA Drug Recalls

Hospira, Inc. has issued a voluntary nationwide recall of one lot of Vancomycin Hydrochloride Injection, USP 1.5g/vial, due to the presence of visible glass particulates observed in multiple vials from one batch. The user level recall affects lot 33045BA, distributed nationwide to wholesalers, distributors, and hospitals throughout the United States and Puerto Rico between June […]

Exela Pharma Sciences, LLC, expands its recall of Sodium Bicarbonate Injection, USP 8.4%, 50 mEq/50 mL Vial, 20-Count Carton with 10 Lots. The ongoing recall which affected forty-nine (49) lots now adds fourteen (14) more lots bringing the total number of recalled lots to sixty-three (63). The 14 more lots of Sodium Bicarbonate Injection, USP,

Pfizer has issued a voluntary nationwide recall of five (5) lots of Accupril (Quinapril HCl) tablets due to the presence of Nitroso-Quinapril. Pfizer distributed the affected products to the patient (consumer/user) level. The recall was initiated after a recent testing revealed that the tablets contained nitrosamine, Nnitroso-quinapril which was above the Acceptable Daily Intake (ADI)

Fagron Inc. has issued a voluntary nationwide recall of its over-the-counter (OTC) liquid medication SyrSpend SF Cherry due to the potential for microbial contamination. The recall affects two lots of SyrSpend SF Cherry and is carried out to the hospital, pharmacy, and distributor level. The microbial Burkholderia gladioli is an opportunistic pathogen that can cause

Teva Pharmaceuticals USA has issued a voluntary nationwide recall of one lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090). The consumer-level recall is being initiated due to failed dissolution test results from one lot. This was discovered during routine stability testing. No other lots are affected by this recall. Risk Statement When this

Green Pharmaceuticals Inc has issued a voluntary nationwide recall of SnoreStop NasoSpray lot 2373/21222 due to the presence of microbial contamination. The consumer-level recall affects products packaged in 0.3 FL OZ (9ml) bottles. The FDA testing discovered the presence of microbial contamination known as Providencia rettgeri. Risk Statement While the microorganism is rarely associated with